Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management around invasive procedures in mastocytosis: An update.
Hermans MAW, Arends NJT, Gerth van Wijk R, van Hagen PM, Kluin-Nelemans HC, Oude Elberink HNG, Pasmans SGMA, van Daele PLA. Hermans MAW, et al. Among authors: van hagen pm, van daele pla. Ann Allergy Asthma Immunol. 2017 Oct;119(4):304-309. doi: 10.1016/j.anai.2017.07.022. Epub 2017 Aug 31. Ann Allergy Asthma Immunol. 2017. PMID: 28866309 Review.
Successful treatment of CRPS 1 with anti-TNF.
Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL. Huygen FJ, et al. Among authors: van hagen pm, van daele pl. J Pain Symptom Manage. 2004 Feb;27(2):101-3. doi: 10.1016/j.jpainsymman.2003.12.006. J Pain Symptom Manage. 2004. PMID: 15157033 Free article. No abstract available.
TB or not TB: treat to see.
van Daele PL, Bakker M, van Hagen PM, Baarsma GS, Kuijpers RW. van Daele PL, et al. Among authors: van hagen pm. Med J Aust. 2006 Aug 7;185(3):178-9. doi: 10.5694/j.1326-5377.2006.tb00515.x. Med J Aust. 2006. PMID: 16893366 No abstract available.
Octreotide long-acting repeatable for the treatment of chronic macular edema in uveitis.
Missotten T, van Laar JA, van der Loos TL, van Daele PL, Kuijpers RW, Baarsma GS, van Hagen PM. Missotten T, et al. Among authors: van hagen pm, van laar ja, van daele pl, van der loos tl. Am J Ophthalmol. 2007 Dec;144(6):838-843. doi: 10.1016/j.ajo.2007.07.039. Epub 2007 Oct 4. Am J Ophthalmol. 2007. PMID: 17916316
Is imatinib mesylate a promising drug in systemic sclerosis?
van Daele PL, Dik WA, Thio HB, van Hal PT, van Laar JA, Hooijkaas H, van Hagen PM. van Daele PL, et al. Among authors: van hagen pm, van laar ja, van hal pt. Arthritis Rheum. 2008 Aug;58(8):2549-52. doi: 10.1002/art.23648. Arthritis Rheum. 2008. PMID: 18668570 Free article.
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA. van Steensel L, et al. Among authors: van den bosch wa, van hagen pm, van daele pl. Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3091-8. doi: 10.1167/iovs.08-2443. Epub 2009 Feb 21. Invest Ophthalmol Vis Sci. 2009. PMID: 19234339
252 results